![](/img/cover-not-exists.png)
Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis: Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons
Strand, V, McInnes, I, Thom, H, Hunger, M, Lopes, N, Gandhi, K, Jugl, SMVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.2960
Date:
October, 2017
File:
PDF, 82 KB
english, 2017